Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Sanofi has agreed to make strategic investment of up to US$25 million in Adagene. The Company plans to use the proceeds to fund its research and development activities, including clinical development ...

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Curcumin contained in turmeric, the main ingredient of curry, can suppress the early onset of colorectal cancer, according to ...

A 56-year-old man from Lebanon died from an extremely rare and aggressive form of colon cancer after suffering subtle ...

Researchers found that clinically achievable doses of curcumin, the active compound in turmeric, target and suppress ...

The company said the therapy is the first allogenic therapy developed with its Tmod technology to be tested in humans.

A University of Alberta research team has identified a DNA structure that activates the immune system in cancer cells that ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Colon cancer is the second leading cause of cancer-related deaths ... may indicate a tumor obstructing the colon. Pain persisting beyond a few days, especially if severe or worsening, should be ...

'Devoted' Special Needs Teacher Has Stage 4 Colon Cancer — After Being Told Tumor Was Benign Karen Kennerley assumed her fatigue was from working so hard — now the mom is trying to raise money ...

This Gut-Healthy Food Could Lower Your Colon Cancer Risk, New Study Suggests Eating at least two servings a week may prevent a certain type of tumor.